MAPK3 and lung adenocarcinoma: Studies have indicated that NLRP3 inflammasome activation enhances the proliferation and metastasis of the lung adenocarcinoma cell line A549, which are mediated by AKT, ERK1/2, and CREB, and upregulation of SNAIL42.